Radiotherapy enhances CXCR3highCD8+ T cell activation through inducing IFNγ-mediated CXCL10 and ICAM-1 expression in lung cancer cells
Cancer Immunology, Immunotherapy · 2023-06 · 72 (6) · 1865-1880
DOI: 10.1007/s00262-023-03379-6 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Immunology, Immunotherapy, online erschienen am 23.01.2023. Verfasst von Chih-Liang Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonary Oncology and Interventional Bronchoscopy, Department of Thoracic Medicine, Chang Gung Memorial Hospital, Linkou, Taoyuan, 333, …. Hauptthemen laut MEDLINE: CD8-Positive T-Lymphocytes, Lung Neoplasms. Die Arbeit wurde bisher 44-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cheng Hsin General Hospital Foundation, the Ministry of Science and Technology, Taiwan, Cheng Gung University.
Abstract (Originalsprache)
Radiotherapy (RT) not only damages tumors but also induces interferon (IFN) expression in tumors. IFNs mediate PD-L1 to exhaust CD8 + T cells, but which also directly impact tumor cells and potentially activate anti-tumor immune surveillance. Little is known about the contradictory mechanism of IFNs in regulating CD8 + T-mediated anti-tumor activity in lung cancer. This study found that RT induced IFNs and CXCL9/10 expression in the RT-treated lung cancer cells. Specifically, RT- and IFNγ-pretreated A549 significantly activated CD8 + T cells, resulting in significant inhibition of A549 colony formation. RNAseq and consequent qPCR results revealed that IFNγ induced PD-L1, CXCL10, and ICAM-1, whereas PD-L1 knockdown activated CD8 + T cells, but ICAM-1 knockdown diminished CD8 + T cell activation. We further demonstrated that CXCR3 and CXCL10 decreased in the CD8 + T cells and nonCD8 + PBMCs, respectively, in the patients with lung cancer that expressed lower reactivation as co-cultured with A549 cells. In addition, inhibitors targeting CXCR3 and LFA-1 in CD8 + T cells significantly diminished CD8 + T cell activation and splenocytes-mediated anti-LL/2shPdl1. In conclusion, we validated that RT suppressed lung cancer and overexpress PD-L1, CXCL10, and ICAM-1, which exhibited different roles in regulating CD8 + T cell activity. We propose that CXCR3 high CD8 + T cells stimulated by CXCL10 exhibit anti-tumor immunity, possibly by enhancing T cells-tumor cells adhesion through CXCL10/CXCR3-activated LFA-1-ICAM-1 interaction, but CXCR3 low CD8 + T cells with low CXCL10 in patients with lung cancer were exhausted by PD-L1 dominantly. Therefore, RT potentially activates CD8 + T cells by inducing IFNs-mediated CXCL10 and ICAM-1 expression in tumors to enhance CD8 + T-tumor adhesion and recognition. This study clarified the possible mechanisms of RT and IFNs in regulating CD8 + T cell activation in lung cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Pulmonary Oncology and Interventional Bronchoscopy, Department of Thoracic Medicine, Chang Gung Memorial Hospital, Linkou, Taoyuan, 333, Taiwan.
- Division of Gastroenterology, Cheng Hsin General Hospital, Taipei, 112, Taiwan.
- Division of Gastroenterology and Hepatology, Department of Internal Medicine, Taipei Medical University Hospital, Taipei, 110, Taiwan.
- Division of Gastroenterology and Hepatology, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, 110, Taiwan.
- TMU Research Center for Digestive Medicine, Taipei Medical University, Taipei, 110, Taiwan.
- Radiation Biology Research Center, Institute for Radiological Research, Chang Gung University, Taoyuan, 333, Taiwan.
Förderung
- Cheng Hsin General Hospital Foundation
- the Ministry of Science and Technology, Taiwan
- Cheng Gung University
Zitieren
APA
Wang, C. L., Ho, A. S., Chang, C. C., Sie, Z. L., Peng, C. L., Chang, J., & Cheng, C. C. (2023). Radiotherapy enhances CXCR3highCD8+ T cell activation through inducing IFNγ-mediated CXCL10 and ICAM-1 expression in lung cancer cells. Cancer Immunology, Immunotherapy, 72(6), 1865-1880. https://doi.org/10.1007/s00262-023-03379-6
Vancouver
Wang CL, Ho AS, Chang CC, Sie ZL, Peng CL, Chang J, et al. Radiotherapy enhances CXCR3highCD8+ T cell activation through inducing IFNγ-mediated CXCL10 and ICAM-1 expression in lung cancer cells. Cancer Immunology, Immunotherapy. 2023;72(6):1865-1880. doi:10.1007/s00262-023-03379-6
BibTeX
@article{Wang2023,
author = {Wang, Chih-Liang and Ho, Ai-Sheng and Chang, Chun-Chao and Sie, Zong-Lin and Peng, Cheng-Liang and Chang, Jungshan and Cheng, Chun-Chia},
title = {Radiotherapy enhances CXCR3highCD8+ T cell activation through inducing IFNγ-mediated CXCL10 and ICAM-1 expression in lung cancer cells},
journal = {Cancer Immunology, Immunotherapy},
year = {2023},
volume = {72},
number = {6},
pages = {1865--1880},
doi = {10.1007/s00262-023-03379-6}
}
EUVIMED